how many people have gone blind from semaglutide Weight-loss jabs may be linked to condition that can cause blindness, study finds | Medical research Scientists Explain 'Ozempic Blindness,' Link

EDV, end-diastolic velocity

Meanwhile, social media companies and advertising platforms need to strictly enforce transparency disclosures on AI-generated ads while closely reviewing all weight loss drug promotions, given the risks of misleading claims and unrealistic expectations

Reported side effects in animal models are minimal

2022 DOI: 10.1016/S0140-6736(22)02033-5 PMID: 36354040 Read on PubMed The Lancet Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Rosenstock J, Frias J, Jastreboff AM, et al

Selenium nanoparticles as new strategy to potentiate gamma delta T cell anti-tumor cytotoxicity through upregulation of tubulin-alpha acetylation

These preclinical findings further implicate glucagon activation as the distinguishing factor between incretin receptor mono-, dual-, and triagonists, and they point to unimolecular polypharmacology as an efficient way to target several mechanisms causing obesity